Alan Prem Kumar
Impact in
- Drug Discovery top 0.2%
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 12
- Oncology 58
- Cytokine Signaling Pathways and Interactions 27
- Cancer Cells and Metastasis 15
- Co-authors
- Gautam Sethi (141 shared papers)Muthu Kumaraswamy Shanmugam (65 shared papers)Frank Arfuso (41 shared papers)Kwang Seok Ahn (48 shared papers)Anupam Bishayee (15 shared papers)Xiaoyun Dai (11 shared papers)Benny K.H. Tan (8 shared papers)Kam Man Hui (25 shared papers)
- Journals
- Cancer Letters (11 papers)International Journal of Molecular Sciences (11 papers)Biomolecules (11 papers)Oncotarget (10 papers)Cancers (9 papers)
- Partner nations
- SingaporeAustraliaUnited States
In The Last Decade
Alan Prem Kumar
263 papers receiving 22.5k citations
Alan Prem Kumar's Hit Papers
Peers
Comparison fields: 5 of 160
- Drug Discovery 81
- Cancer Research 2.7k
- Complementary and alternative medicine 1.8k
- Oncology 3.3k
- Molecular Biology 6.9k
Countries citing papers authored by Alan Prem Kumar
This map shows the geographic impact of Alan Prem Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Prem Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Prem Kumar more than expected).
Fields of papers citing papers by Alan Prem Kumar
This network shows the impact of papers produced by Alan Prem Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Prem Kumar. The network helps show where Alan Prem Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Prem Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 269 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer Hit paper breakdown → | 2023 | 1358 |
| 2 | The Role of Resveratrol in Cancer Therapy Hit paper breakdown → | 2017 | 682 |
| 3 | Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors Hit paper breakdown → | 2014 | 568 |
| 4 | Dual role of autophagy in hallmarks of cancer Hit paper breakdown → | 2017 | 465 |
| 5 | Emerging role of exosomes in cancer progression and tumor microenvironment remodeling Hit paper breakdown → | 2022 | 462 |
| 6 | Thymoquinone: Potential cure for inflammatory disorders and cancer Hit paper breakdown → | 2011 | 454 |
| 7 | 2015 | 442 | |
| 8 | 2018 | 406 | |
| 9 | 2015 | 321 | |
| 10 | 2011 | 291 | |
| 11 | 2013 | 291 | |
| 12 | Targeting autophagy using natural compounds for cancer prevention and therapy Hit paper breakdown → | 2019 | 275 |
| 13 | 2012 | 258 | |
| 14 | 2017 | 249 | |
| 15 | 2013 | 246 | |
| 16 | 2014 | 239 | |
| 17 | 2016 | 237 | |
| 18 | 2018 | 211 | |
| 19 | 2016 | 205 | |
| 20 | 2021 | 202 |
About Alan Prem Kumar
Alan Prem Kumar is a scholar working on Cancer Research, Oncology, Molecular Biology, Complementary and alternative medicine and Pharmacology, having authored 269 papers that have together received 22.8k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (27 papers), Cancer Cells and Metastasis (15 papers), Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (12 papers), Natural product bioactivities and synthesis (11 papers), Peroxisome Proliferator-Activated Receptors (11 papers), Autophagy in Disease and Therapy (11 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). The work is most often cited by research in Drug Discovery (81 citations), Cancer Research (2.7k citations), Complementary and alternative medicine (1.8k citations), Oncology (3.3k citations) and Molecular Biology (6.9k citations). Alan Prem Kumar has collaborated with scholars based in Singapore, Australia and United States. Frequent co-authors include Gautam Sethi, Muthu Kumaraswamy Shanmugam, Frank Arfuso, Kwang Seok Ahn, Anupam Bishayee, Xiaoyun Dai, Benny K.H. Tan, Kam Man Hui, Kodappully Sivaraman Siveen and Milad Ashrafizadeh. Their work appears in journals such as Cancer Letters, International Journal of Molecular Sciences, Biomolecules, Oncotarget and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.